Mrs Cheyenne Buckner, ATC, LAT | |
1609 W Elm St, El Reno, OK 73036-4261 | |
(405) 467-6782 | |
Not Available |
Full Name | Mrs Cheyenne Buckner |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
Location | 1609 W Elm St, El Reno, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427557339 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Cheyenne Buckner, ATC, LAT 1609 W Elm St, El Reno, OK 73036-4261 Ph: (405) 467-6782 | Mrs Cheyenne Buckner, ATC, LAT 1609 W Elm St, El Reno, OK 73036-4261 Ph: (405) 467-6782 |
News Archive
A new study published in CJASN found that functional decline within the first 6 months after initiating dialysis was highly prevalent in older adults at 17 centers in Netherlands, and the risk was higher in those with advanced age and frailty.
In the midst of bankruptcy proceedings, Kodak withdrew a motion to end these health benefits and will instead create a reitrees commitee to examine issues of medical and survivor benefits. Meanwhile, AT&T contract negotiations continue - with health care premiums and copayments among the issues in play.
The shortage of flu vaccines and the DHSSPS's public handling of the situation has caused anger amongst many of Northern Ireland's GPs.
Genentech, a member of the Roche Group, today announced positive results from the Phase III CLL11 study. At a pre-planned interim analysis, an independent data monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to Rituxan (rituximab) plus chlorambucil.
› Verified 8 days ago